Table 1.
Composition chitosan tablet formulations with Chelidonii herba lyophilized extract.
| Placebo 1 (P1) | Formulation 1 (F1) | Placebo 2 (P2) | Formulation 2 (F2) | Placebo 3 (P3) | Formulation 3 (F3) | |
|---|---|---|---|---|---|---|
| Content (mg) of Compounds in One Tablet | ||||||
| Chelidonii herba lyophilized extract + Aerosil 5:1 | - | 120.0 | - | 120.0 | - | 120.0 |
| Chitosan 80/500 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 |
| HPMC | - | - | 50.0 | 50.0 | 100.0 | 100.0 |
| Microcrystalline cellulose (Avicel 102) | 50.0 | 50.0 | 50.0 | 50.0 | 50.0 | 50.0 |
| Lactose monohydrate | 130.0 | 130.0 | 80.0 | 80.0 | 30.0 | 30.0 |
| Magnesium stearate | 4.0 | 4.0 | 4.0 | 4.0 | 4.0 | 4.0 |
| Sum | 284.0 | 404.0 | 284.0 | 404.0 | 284.0 | 404.0 |